APOE e4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals

The hippocampus is affected early in Alzheimer's disease (AD) and altered hippocampal functioning influences normal cognitive aging. Here, we used task-based functional MRI to assess if the APOE e4 allele or a polygenic risk score (PRS) for AD was linked to longitudinal changes in memory-related hippocampal activation in normal aging (baseline age 50-95, n = 292; n = 182 at 4 years follow-up, subsequently non-demented for at least 2 years). Mixed-models were used to predict level and change in hippocampal activation by APOE e4 status and PRS based on gene variants previously linked to AD at p <= 1, p < 0.05, or p < 5e-8 (excluding APOE). APOE e4 and PRSp<5e-8 significantly predicted AD risk in a larger sample from the same study population (n = 1542), while PRSp <= 1 predicted memory decline. APOE e4 was linked to decreased hippocampal activation over time, with the most prominent effect in the posterior hippocampi, while PRS was unrelated to hippocampal activation at all p-thresholds. These results suggests a link for APOE e4, but not for AD genetics in general, on functional changes of the hippocampi in normal aging.

Automated summary

This study examined the relationship between APOE e4 allele or polygenic risk score (PRS) for Alzheimer's disease (AD) and longitudinal changes in memory-related hippocampal activation in normal aging. The results showed that APOE e4 was associated with decreased hippocampal activation over time, while PRS was not related to hippocampal activation.